Rikard Sandström

839 total citations
18 papers, 677 citations indexed

About

Rikard Sandström is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Rikard Sandström has authored 18 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Oncology. Recurrent topics in Rikard Sandström's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Rikard Sandström is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Rikard Sandström collaborates with scholars based in Sweden, Denmark and Switzerland. Rikard Sandström's co-authors include Hans Lennernäs, Anders Karlsson, Lars Knutson, Håkan Olsson, Tina W. Knutson, Bjarke M. Klein, Jens Peter Nørgaard, Lars Erichsen, Lars Grundemar and Kristian Vinter Juul and has published in prestigious journals such as Journal of Clinical Microbiology, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Rikard Sandström

17 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rikard Sandström Sweden 13 304 210 201 103 101 18 677
Wen-Sheng Guo United States 5 401 1.3× 324 1.5× 218 1.1× 54 0.5× 28 0.3× 5 628
Yayoi Hayashi Japan 17 269 0.9× 143 0.7× 84 0.4× 197 1.9× 117 1.2× 39 817
Jiřina Martı́nková Czechia 16 145 0.5× 112 0.5× 151 0.8× 113 1.1× 8 0.1× 45 693
Vikram Arya United States 18 479 1.6× 359 1.7× 280 1.4× 177 1.7× 70 0.7× 50 1.1k
Justina C. Calamia United States 19 275 0.9× 257 1.2× 326 1.6× 346 3.4× 21 0.2× 22 1.1k
L. Giuliani Italy 18 188 0.6× 154 0.7× 296 1.5× 237 2.3× 13 0.1× 44 806
Frank W. Lee United States 13 184 0.6× 79 0.4× 218 1.1× 173 1.7× 29 0.3× 21 698
Landry K. Kamdem United States 12 338 1.1× 229 1.1× 326 1.6× 162 1.6× 9 0.1× 21 898
Constantin Efthymiopoulos United Kingdom 12 88 0.3× 55 0.3× 51 0.3× 96 0.9× 138 1.4× 16 636
Rossen Koytchev Bulgaria 14 62 0.2× 87 0.4× 69 0.3× 39 0.4× 25 0.2× 45 568

Countries citing papers authored by Rikard Sandström

Since Specialization
Citations

This map shows the geographic impact of Rikard Sandström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikard Sandström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikard Sandström more than expected).

Fields of papers citing papers by Rikard Sandström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikard Sandström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikard Sandström. The network helps show where Rikard Sandström may publish in the future.

Co-authorship network of co-authors of Rikard Sandström

This figure shows the co-authorship network connecting the top 25 collaborators of Rikard Sandström. A scholar is included among the top collaborators of Rikard Sandström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rikard Sandström. Rikard Sandström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Olsson, Håkan, et al.. (2014). Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men. Clinical Pharmacology in Drug Development. 3(5). 358–364. 9 indexed citations
3.
Olsson, Håkan, Rikard Sandström, & Lars Grundemar. (2014). Different pharmacokinetic and pharmacodynamic properties of recombinant follicle‐stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non‐human cell line. The Journal of Clinical Pharmacology. 54(11). 1299–1307. 54 indexed citations
4.
Juul, Kristian Vinter, Bjarke M. Klein, Rikard Sandström, Lars Erichsen, & Jens Peter Nørgaard. (2011). Gender difference in antidiuretic response to desmopressin. American Journal of Physiology-Renal Physiology. 300(5). F1116–F1122. 99 indexed citations
5.
Karlsson, Mats O., et al.. (2007). A mechanistic model describing the impact of carbamazepine on the pharmacokinetics of clomethiazole and its metabolite NLA-715. 1 indexed citations
6.
Dahl, M-L, et al.. (2007). Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin. Clinical Pharmacology & Therapeutics. 84(1). 52–62. 70 indexed citations
7.
8.
Sandström, Rikard, et al.. (2004). Quantitative analysis of eight testosterone metabolites using column switching and liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 18(10). 1089–1094. 20 indexed citations
9.
Svensson, U, Rikard Sandström, Örjan Carlborg, Hans Lennernäs, & Michael Ashton. (1999). High In Situ Rat Intestinal Permeability of Artemisinin Unaffected by Multiple Dosing and with No Evidence of P-glycoprotein Involvement. Drug Metabolism and Disposition. 27(2). 227–232. 53 indexed citations
10.
Sandström, Rikard, Tina W. Knutson, Lars Knutson, Britt Jansson, & Hans Lennernäs. (1999). The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)‐verapamil in humans. British Journal of Clinical Pharmacology. 48(2). 180–189. 62 indexed citations
11.
Sandström, Rikard, et al.. (1999). Enantiomeric separation of verapamil and norverapamil using Chiral-AGP® as the stationary phase. Journal of Pharmaceutical and Biomedical Analysis. 21(1). 43–49. 25 indexed citations
12.
Sandström, Rikard & Hans Lennernäs. (1999). Repeated Oral Rifampicin Decreases the Jejunal Permeability of R/S-Verapamil in Rats. Drug Metabolism and Disposition. 27(8). 951–955. 28 indexed citations
13.
Sandström, Rikard, et al.. (1998). Jejunal Absorption and Metabolism of R/S-Verapamil in Humans. Pharmaceutical Research. 15(6). 856–862. 83 indexed citations
14.
Sandström, Rikard, Anders Karlsson, & Hans Lennernäs. (1998). The Absence of Stereoselective P-Glycoprotein-mediated Transport ofR/S-Verapamil Across the Rat Jejunum. Journal of Pharmacy and Pharmacology. 50(7). 729–735. 48 indexed citations
15.
Lindahl, Anders, Rikard Sandström, Anna‐Lena Ungell, & Hans Lennernäs. (1998). Concentration- and Region-dependent Intestinal Permeability of Fluvastatin in the Rat. Journal of Pharmacy and Pharmacology. 50(7). 737–744. 26 indexed citations
16.
Sandström, Rikard. (1998). Intestinal permeability and presystemic metabolism of R/S-verapamil and fluvastatin. 1 indexed citations
17.
Lindahl, Anders, Rikard Sandström, Anna‐Lena Ungell, et al.. (1996). Jejunal permeability and hepatic extraction of fluvastatin in humans. Clinical Pharmacology & Therapeutics. 60(5). 493–503. 65 indexed citations
18.
Sandström, Rikard, et al.. (1983). Cephalexin-supplemented Jones-Kendrick charcoal agar for selective isolation of Bordetella pertussis: comparison with previously described media. Journal of Clinical Microbiology. 17(1). 60–62. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026